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The range of intraocular pressure (IOP), among the
general population, varies from 8-22 mmHg [1]. This
variation can be explained by the numerous factors
affecting IOP. Previous studies have shown that the
factors associated with elevated IOP include smoking
[2], older age [3], gender [2,3], blood pressure [2-4]
family history of glaucoma [2,3], pulse rate [2,3],
diabetes (elevated glycosylated hemoglobin) [2,3],
myopia [5], alcohol usage [2], race (African) [4], nuclear
sclerosis [3,5], body mass index (BMI) [2-4] and iris
color [5].
Subjects with type 2 diabetes mellitus (DM) have an
increased risk of developing open angle glaucoma [6]. It
is important to study the distribution and effect of the
factors affecting IOP among subjects with DM in India,
as there are few population-based studies regarding the
same [7]. Based on the procedure used and the
population chosen, the distribution of intraocular
pressure among type 2 DM varied from 14.86 to 21.5
mmHg [2,3,7-18]. 
However, these studies did not have standardized
procedures like goldmann applanation tonometer (GAT)
and fundus photography based standardized retinopathy
grading. The aim of this study is to describe the IOP
distribution and the factors affecting IOP in subjects with
type 2 DM. It also elucidates the gender-specific
influence of these factors on the IOP.
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Sankara Nethralaya - Diabetic Retinopathy Epidemio-
logy and Molecular Genetic Study (SN- DREAMS 1) is
a population-based, cross-sectional, study to estimate the
prevalence and risk factors of diabetes and diabetic
retinopathy in the South-Indian population. The detail
methodology and study design of SN-DREAMS 1 is
given elsewhere [19].
The study population was selected by multistage,
systematic random sampling based on the socio-
economic status, which made the sample a true
representation of subjects with type 2 DM in India. Out
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Objectives: This study was conducted to show the intraocular pressure (IOP) distribution and the factors affecting IOP in
subjects with type 2 diabetes mellitus (DM) in India.
Methods: We measured the anthropometric and biochemical parameters for confirmed type 2 DM patients. A
comprehensive ocular examination was performed for 1377 subjects aged > 40 years and residing in Chennai.
Results: A significant difference in IOP (mean  standard deviation) was found between men and women (14.62.9 and
15.02.8 mmHg, p = 0.005). A significantly elevated IOP was observed among smokers, subjects with systemic hypertension
and women with clinically significant macular edema (CSME). After a univariate analysis, factors associated significantly with
higher IOP were elevated systolic blood pressure, elevated resting pulse rate and thicker central corneal thickness (CCT). In
women, elevated glycosylated hemoglobin was associated with a higher IOP. After adjusting for all variables, the elevated
resting pulse rate and CCT were found to be associated with a higher IOP.
Conclusions: Systemic hypertension, smoking, pulse rate and CCT were associated with elevated intraocular pressure in
type 2 DM. Women with type 2 DM, especially those with CSME, were more prone to have an elevated IOP.
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cc of the 5999 individuals, aged 40 , enumerated from the
general population, 1816 subjects had diabetes (known
1349 and provisional 469); 1563 (86.1%) subjects came
for further evaluation at the base hospital and of these,
138 subjects with no diabetes and 11 subjects with
ungradable retinal photographs were excluded. Apart
from this, 30 subjects having IOP  22 mmHg, three
glaucoma suspects and four subjects under anti-glaucoma
medication (one of them being ocular hypertensive) were
excluded from the study. Finally, we had 1377 subjects
for this study. Known diabetics and provisional diabetics
were selected in accordance with the ADA criterion [20].
Known diabetes is when diabetes is diagnosed by a
medical practitioner, or the patient uses hypoglycemic
medication, either oral or insulin or both and provisional
diabetes is when the condition is diagnosed in a new
asymptomatic individual with a first fasting blood
glucose level 110 mg/dL (Accutrend alpha). The right
eye was chosen for analysis, alternatively the eye without
any history of ocular surgery was selected for analysis.
The study was approved by the Institutional Review
Board and a written informed consent was obtained from
the subjects as per the Helsinki Declaration. Subjects
with provisional diabetes were confirmed to be having
diabetes by re-estimating fasting blood glucose by
enzymatic assay based glucose oxidation method
(Accutrend alpha) [20]. The biochemical analyses done
using the Merck Micro Lab 120, semi automated
analyzer included total serum cholesterol (CHOD-POD
method), high-density lipoproteins (after protein
precipitation CHOD-POD method), serum triglycerides
(CHOD-POD), hemoglobin (calorimetric hemoglo-
binometer), packed cell volume (capillary method) and
the glycosylated hemoglobin fraction (Bio-Rad
DiaSTAT HbA1c Reagent Kit).
Anthropometric measurements, including weight,
height, waist and hip, were obtained using standardized
techniques. The blood pressure was recorded, in the
sitting position, in the right arm, to the nearest 2 mmHg
using the mercury sphygmomanometer (Diamond
Deluxe BP apparatus, Pune, India). Two readings were
taken, five minutes apart, and their mean, was taken as
the blood pressure. Microalbuminuria was estimated
using the first morning urine sample, by a semi-
quantitative procedure (Clintek 50 Bayer Urine
Analyzer) in which the subjects were considered to have
microalbuminuria, if the albumin creatinine ratio (ACR)
was between 30 and 299 mg/g [21]. Diabetic neuropathy
was assessed by measuring the vibration perception
threshold (VPT) using a sensitometer by a single
observer with a biothesiometer probe placed
perpendicular to the distal plantar surface of the great toe
in both legs. The mean VPT measure of the three
readings of both legs was considered for the analysis.
The presence of diabetic neuropathy was considered if
the VPT value was >20 V [22].
After the initial phases of sampling, diabetes
confirmation, biochemical and anthropometric
examination, a comprehensive ophthalmic examination
was conducted at a dedicated facility created in the base
hospital in a pre-determined specific order - starting
from the subject’s medical and ophthalmic condition to
recording the presenting and the best-corrected distance
visual acuity using the modified ETDRS chart (Light
House Low Vision Products, New York, NY, USA). For
those who could not read the English alphabet, the
Landolt’s ring was shown. The pinhole visual acuity was
assessed for those having visual acuity less than 4/4
(LogMAR 0.0). An objective refraction was performed
with a streak retinoscope (Beta 200, Heine, Germany)
and was followed by subjective refraction. The corneal
endothelial status was assessed with the corneal specular
microspcopy, the corneal thickness was measured using
the Corneal Pachymeter (Alcon ultrasound pachymeter)
after which the slit lamp examination was performed
(Zeiss SL 130). The peripheral anterior chamber depth
was assessed as per the van Herick grading [23] and the
iris was examined for neovascularization. The IOP in
both the eyes were measured using Goldmann
applanation tonometer (Zeiss AT 030 Applanation
Tonometer, Carl Zeiss, Jena, Germany), using 0.05%
proparacaine eyedrops as topical anaesthesia and 2%
fluorescein to stain the tear film [24]. The IOP in the
right eye was measured first and taken for analysis (Intra
correlation coefficient 0.84 between the eyes), with only
one reliable measurement recorded for each. The
instrument was calibrated on the first working day of
every week. After dilating the pupils with 5%
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Figure 1. Distribution of intraocular pressure in
subjects with type 2 diabetes mellitus.*OUSBPDVMBS1SFTTVSFJO5ZQF%JBCFUFT.FMMJUVT
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Table 1. Distribution of Intraocular pressure in various subgroups among subjects with type 2 diabetes mellitus
MeanSD
Risk factors
Over all (n=1377)
n IOP (mmHg) p n IOP (mmHg) p n IOP (mmHg) p
Men (n=731) Women (n=646)
Mean IOP
Demography
Age (y)
40 - 49
50 - 59
60 - 69
70 +
Duration of diabetes (y)
< 5
 5
Nuclear cataract
Absent
Present
Alcohol history
Absent
Present
Refractive error
Absent
Present
Family history of glaucoma
Absent
Present
Smoking status
Non smoker
Smoker
Insulin
Non user of insulin
User of insulin
Anthropometry
BMI
Lean 
Normal 
Overweight 
Obese 
Height (cm)
 156
> 156
Weight (kg)
< 57.5
 57.5
Axial length (mm)
<  22.6
 22.6
Hypertension
No
Yes
Systolic BP (mmHg)
< 130
 130
Diastolic BP (mmHg)
<8 0
 80
Biochemical
Serum total cholesterol  (mg/dL)
< 200
 200
385
494
342
156
799
578
1011
187
1074
303
511
866
1371
6
1106
271
1310
67
87
522
562
206
586
791
410
967
565
786
499
878
401
976
429
948
883
493
14.8  2.9
14.7  2.7
14.9  2.9
14.7  2.9
14.7  2.9
14.8  2.8
14.7  2.9
14.8  0.438
15.0  0.439
14.9  2.9
14.4  2.9
14.8  2.9
14.8  2.9
14.8  2.9
14.5  2.8
14.3  2.9
14.9  2.9
14.8  2.9
15.1  3.1
14.2  2.9
14.8  3.0
14.9  2.7
14.9  2.9
15.0  2.7
14.6  2.9
14.7  2.9
14.8  2.9
14.7  2.9
14.9  2.9
14.6  2.9
14.9  2.9
14.4  2.9
14.9  2.9
14.7  2.9
14.9  2.9
14.7  2.9
14.9  2.8
0.69
0.51
0.44
0.002
0.67
0.92
0.001
0.46
0.19
0.007
0.50
0.25
0.03
0.001
0.27
0.30
210
245
178
98
403
328
550
93
428
303
287
444
727
4
460
271
698
33
66
365
258
42
652
79
208
523
257
465
300
431
242
489
241
490
511
219
14.6  2.9
14.4  2.6
14.8  3.1
14.6  3.0
14.6  3.1
14.7  2.9
14.4  2.9
14.6  2.9
14.8  3.0
14.8  2.9
14.4  2.9
14.5  3.0
14.6  2.9
14.6  2.9
13.5  3.0
14.3  2.9
14.8  2.9
14.6  2.9
15.0  3.3
14.2  2.9
14.7  3.1
14.5  2.8
14.6  2.8
14.6  2.9
14.6  2.8
14.7  3.1
14.6  2.9
14.3  2.9
14.8  2.9
14.4  2.9
14.7  2.9
14.1  2.8
14.8  2.9
14.4  2.9
14.7  2.9
14.6  2.9
14.6  2.8
0.59
0.21
0.57
0.06
0.64
0.50
0.021
0.42
0.50
0.95
0.08
0.03
0.10
0.003
0.17
0.95
175
249
164
58
396
250
461
94
646
0
224
422
224
422
646
0
612
34
21
157
304
164
619
27
163
483
308
321
199
447
159
487
188
458
372
274
15.0  2.8
15.1  2.8
15.1  2.8
14.9  2.9
15.0  2.6
14.9  2.7
15.1  2.9
15.1  2.8
15.2  2.1
15.0  2.8
-
15.0  2.7
15.0  2.8
15.0  2.8
16.5  0.71
15.0  2.8
-
15.0  2.8
15.1  3.0
14.1  3.1
14.9  2.9
15.2  2.7
14.9  2.9
15.1  2.8
14.0  3.0
14.8  2.8
15.1  2.8
15.0  2.7
15.1  2.9
14.9  2.8
15.1  2.8
14.8  2.9
15.1  2.8
15.0  2.8
15.0  2.8
14.9  2.8
15.2  2.8
0.005
0.94
0.49
0.69
-
0.93
0.39
-
0.87
0.38
0.06
0.26
0.97
0.33
0.21
0.94
0.36
STDR: sight threatening diabetic retinopathy (severe Nonproliferative diabetic retinopathy, proliferative diabetic retinopathy and clinically significant
macular edema), CSME:  clinically significant macular edema, HbA1c: glycosylated hemoglobin, BP: blood pressure, CCT: central corneal thickness,
BMI: body mass index, FBS: fasting blood sugar.phenylephrine and 1% tropicamide eyedrops (if
phenylephrine is contraindicated, 1% cyclopentolate
eyedrops used), lens opacities were graded using the
Lens Opacities Classification System (LOCS chart III,
Leo T. Chylack, Harvard Medical School, Boston, MA),
retro illuminated with a light box. Fundus photographs
were taken using the 45 four-field stereoscopic digital
photography Carl Zeiss fundus camera (Visucamlite,
Jena, Germany). Diabetic retinopathy was diagnosed
based on the modified Klein classification (Modified
Early Treatment Diabetic Retinopathy Study scales)
[25]. The diabetic retinopathy grading was done by two
independent observers in a masked fashion and the
grading agreement of both were high (k=0.83). 
Glycemic control was categorized as normal
(glycosylated hemoglobin [HbA1c] <5.6), good (HbA1c
5.6 -7.0), fair (HbA1c 7.1- 8.0) and poor (HbA1c  8.1)
[20]. The fasting plasma glucose was considered to be
high if the value was >126 mg/dL [26]. The height and
weight of all subjects were noted, after which the body
mass index (BMI) was calculated using the formula:
weight (kg)/height (m
2) [27]. Based on the BMI,
individuals were classified as lean (male, <20; female,
<19), normal (male, 20-25; female, 19-24), overweight
(male, 25-30; female, 24-29) or obese (male, >30;
female, >29) [28]. The mean Indian height and weight
(Indian Council of Medical Research, 1990), axial length
[27], CCT [29], pulse beat [30] was taken for general
characteristics, whereas, total cholesterol, high and low
density cholesterol, triglycerides levels were taken from
a previous study [31].
Along with the age and gender-specific mean IOP (
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Table 1. Continued                                                                                                                                         MeanSD
Risk factors
Over all (n=1377)
n IOP (mmHg) p n IOP (mmHg) p n IOP (mmHg) p
Men (n=731) Women (n=646)
Serum high density lipoproteins (mg/dL)
 60
< 60
Serum triglycerides (mg/dL)
< 150
150
HbA1c (%)
Normal (< 5.6)
Good  to Fair (5.6 - 8.0)
Poor (8.1)
Albuminuria
No micro / macroalbuminuria
Microalbuminuria
Macroalbuminuria
FBS (mg/dL)
<  126
 126
CCT (microns)
< 511
 511
Pulse (Beats/min)
<  80
 80
Diabetes complications
Diabetic  retinopathy
Absent
Present
STDR
Absent
Present
CSME
Absent
Present
Diabetic neuropathy
Absent
Present
1327
49
848
528
97
654
626
1123
217
37
402
975
466
911
960
417
1130
247
1333
44
1361
16
1113
251
14.8  2.9
15.0  2.9
14.7  2.9
14.9  2.9
14.7  2.9
14.7  2.8
14.9  2.9
14.8  2.8
15.0  3.1
14.5  2.7
14.8  2.9
14.8  2.9
14.5  2.8
14.9  2.9
14.6  2.9
15.2  2.8
14.8  2.8
14.7  3.1
14.8  2.9
14.5  3.1
14.8  2.9
15.7  3.1
14.9  2.8
14.4  2.9
0.56
0.37
0.31
0.43
0.85
0.002
<0.0001
0.44
0.54
0.29
0.008
715
15
448
282
49
346
336
594
115
22
226
505
233
498
529
202
578
155
702
29
722
9
581
146
14.6  2.9
14.7  3.1
14.5  2.9
14.7  2.9
14.9  3.1
14.5  2.9
14.6  2.9
14.6  2.9
14.5  3.2
14.5  2.9
14.6  3.1
14.6  2.9
14.3  2.9
14.7  2.9
14.4  2.9
15.1  2.8
14.6  2.9
14.2  3.1
14.6  2.9
13.9  2.9
14.6  2.9
14.1  3.0
14.7  2.9
14.2  2.9
0.93
0.56
0.72
0.96
0.94
0.07
0.003
0.39
0.23
0.62
0.06
612
34
400
246
48
308
290
529
102
15
176
470
233
413
431
215
554
92
631
15
639
7
532
105
15.0  2.8
15.2  2.8
14.9  2.7
15.1  2.9
14.5  2.8
14.8  2.7
15.3  2.9
14.9  2.7
15.6  2.9
14.5  2.6
15.0  2.6
15.0  2.9
14.6  2.7
15.3  2.8
14.9  2.8
15.3  2.8
15.0  2.7
15.1  3.1
15.0  2.7
15.7  3.2
15.0  2.8
17.4  2.2
15.1  2.8
14.6  2.9
0.72
0.46
0.06
0.09
0.97
0.004
0.06
0.77
0.38
0.02
0.09
STDR: sight threatening diabetic retinopathy (severe nonproliferative diabetic retinopathy, proliferative diabetic retinopathy and clinically significant
macular edema), CSME:  clinically significant macular edema, HbA1c: glycosylated hemoglobin, BP: blood pressure, CCT: central corneal thickness,
BMI: body mass index, FBS: fasting blood sugar.*OUSBPDVMBS1SFTTVSFJO5ZQF%JBCFUFT.FMMJUVT
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standard deviation [SD]), the mean IOP ( SD), based
on the stratification of each categorical predictor, was
also calculated. Analysis of variance (ANOVA) was
used to compare the demographic, anthropometric,
biochemical factors with the IOP. Beta values were
calculated for the continuous variables. Both unadjusted
and adjusted regression analysis was performed for the
variables. All analysis was done using SPSS version
15.0 (SPSS Inc., Chicago, IL). A p value of 0.05 was
considered significant. 
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Figure 1 shows the normal distribution of intraocular
pressure among subjects with type 2 diabetes. The mean
IOP was 14.82.9 mmHg (men 14.62.9 and women
15.02.8 mmHg, p=0.005). There was no significant
difference between the mean IOP in the right and left
eye (p=0.185). Table 1 shows the IOP distribution in
various sub-groups. Subjects with hypertension and a
raised systolic blood pressure (SBP) had a higher IOP
than those without (14.92.9 vs 14.62.9 mmHg,
p=0.03 and 14.92.9 vs 14.42.9 mmHg, p=0.001
respectively). Those with diabetic neuropathy had a
lower IOP than those without (14.42.9 vs 14.92.8
mmHg, p=0.008). Among women subjects, those with
clinically significant macular edema (CSME) had a
higher IOP than those without CSME (17.42.2 vs 15.0
2.8 mmHg, p=0.02). Smokers had a higher IOP than
non-smokers (14.92.9 vs 14.32.9, p=0.001)
whereas, alcoholics had a lower IOP than non-alcoholics
(14.42.9 vs 14.92.9, p=0.002). Short stature, high
central cormeal thickness (CCT) and raised pulse beat
were significantly associated with a higher IOP, whereas,
longer axial length was significantly associated with a
higher IOP only in men subjects. Table 2 describes the
correlation of the continuous variables with the
intraocular pressure. height, SBP, pulse, CCT and serum
total cholesterol were the variables found to be
significantly associated with intraocular pressure. Pulse
(men: r=0.076, p=0.021 and women r=0.058, p=0.011)
and CCT (men: r=0.12, p=0.001 and women r=0.182,
p<0.001) were the variables associated with an elevated
IOP in men and women.
Table 3 shows the gender-specific unadjusted analysis
for continuous variables associated with IOP in subjects
with type 2 diabetes. Factors associated with an elevated
IOP included elevated systolic blood pressure (ǰ =0.008,
p=0.024), elevated resting pulse rate (ǰ =0.019,
p=0.006) and thicker central corneal thickness (ǰ
=0.011, p<0.001). Height was associated with a
decrease in the IOP (ǰ =-0.024, p=0.008). In men, the
factors associated with an elevated IOP included higher
resting pulse rate (ǰ =0.021, p=0.04), thicker CCT (ǰ
=0.01, p=0.001) and systolic blood pressure (ǰ = 0.011,
p=0.04); in women, elevated glycosylated hemoglobin
(ǰ =0.1, p =0.04) and CCT (ǰ =0.015, p <0.001) were
significant factors.
After adjusting the continuous variables associated
with IOP in subjects with type 2 diabetes, the factors
associated with elevated IOP are included in Table 4 as
Table 2. Correlation with intraocular pressure
Variable r p
Over All
Age (y)
Duration of diabetes (y)
Weight (Kg)
Height (cm)
Systolic BP (mmHg)
Diastolic BP (mmHg)
Pulse (Beats/min)
CCT (Ǻ )
Axial Length (mm)
Serum Total cholesterol (mg/dL)
Serum high density lipoproteins  (mg/dL)
Serum Triglycerides (mg/dL)
HbA1C (%)
FBS (mg/dL)
Men
Age (y)
Duration of diabetes (y)
Weight (Kg)
Height (cm)
Systolic BP (mmHg)
Diastolic BP (mmHg)
Pulse (Beats/min)
CCT (Ǻ )
Axial length (mm)
Serum total cholesterol  (mg/dL)
Serum high density lipoproteins  (mg/dL)
Serum triglycerides (mg/dL)
HbA1C (%)
FBS (mg/dL)
Women
Age (y)
Duration of diabetes (y)
Weight (kg)
Height (cm)
Systolic BP (mmHg)
Diastolic BP (mmHg)
Pulse (Beats/min)
CCT (Ǻ )
Axial length (mm)
Serum total cholesterol (mg/dL)
Serum high density lipoproteins  (mg/dL)
Serum triglycerides (mg/dL)
HbA1C (%)
FBS (mg/dL)
-0.015
-0.035
-0.012
-0.012
0.061
0.041
0.074
0.139
0.026
0.047
0.003
0.021
0.035
0.045
0.014
-0.061
-0.011
-0.029
0.076
0.057
0.076
0.120
0.057
0.013
-0.008
0.027
-0.003
0.047
-0.041
0.025
0.016
-0.027
0.029
0.015
0.058
0.182
0.018
0.063
-0.008
0.037
0.080
0.039
0.2900
0.0900
0.3300
0.0040
0.0100
0.0600
0.0030
< 0.001
0.1600
0.0400
0.4500
0.1600
0.1000
0.0400
0.3500
0.0500
0.3800
0.2150
0.0200
0.0600
0.0200
0.0000
0.0600
0.3600
0.4100
0.2300
0.4700
0.1000
0.1400
0.2600
0.3400
0.2400
0.2300
0.3500
0.0100
<0.001
0.3300
0.0500
0.4100
0.1700
0.0200
0.1600
BP: blood pressure, CCT: central corneal thickness, 
HbA1c: glycosylated hemoglobin, FBS: fasting blood sugar. 4BZBOUBO#JTXBT
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thicker central corneal thickness (ǰ =0.011, p<0.001)
and elevated resting pulse rate (ǰ =0.001, p =0.03);
height was associated with a decrease in the IOP (ǰ =-
0.028, p =0.008). A thicker central corneal thickness
was the single variable associated with an elevated IOP
in men and women (men: ǰ =0.01, p=0.002 and
women ǰ =0.015, p <0.001). 
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The supplementary Table shows the comparison of the
mean IOP in published population-based reports among
type 2 diabetes. The mean IOP among diabetics in our
study was lower than other studies [2,8,9]. When
compared to other races, the IOP in the Asian ethnicity is
lower [7,10]. The Barbados Eye Study and the Los
Angeles Latino Eye Study, like our study, has also found
Table 3. Univariate associations with Intraocular Pressure (IOP) in participants of SN DREAMS 1
Risk factors
Unadjusted
ǰ ǰ
95% CI
Lower bound Upper bound
SE p
Over All
Age (y)
Duration of diabetes (y)
Weight (Kg)
Height (cm)
Systolic BP (mmHg)
Diastolic BP (mmHg)
Pulse (Beats/min)
CCT (Ǻ )
Axial length (mm)
Serum total cholesterol  (mg/dL)
Serum high density lipoproteins  (mg/dL)
Serum triglycerides (mmg/dL)
HbA1C (%)
FBS (mg/dL)
Men
Age (y)
Duration of diabetes (y)
Weight (Kg)
Height (cm)
Systolic BP (mmHg)
Diastolic BP (mmHg)
Pulse (Beats/min)
CCT (Ǻ )
Axial length (mm)
Serum total cholesterol (mg/dL)
Serum high density lipoproteins (mg/dL)
Serum triglycerides (mg/dL)
HbA1C (%)
FBS (mg/dL)
Women
Age (y)
Duration of diabetes (in years)
Weight (kg)
Height (cm)
Systolic BP (mmHg)
Diastolic BP (mmHg)
Pulse (Beats/min)
CCT (Ǻ )
Axial length (mm)
Serum total cholesterol (mg/dL)
Serum high density lipoproteins  (mg/dL)
Serum triglycerides (mg/dL)
HbA1C (%)
FBS (mg/dL)
-0.004
-0.016
-0.003
-0.024
0.008
0.010
0.019
0.011
0.061
0.003
0.001
0.001
0.045
0.002
0.004
-0.027
-0.003
-0.013
0.011
0.015
0.021
0.010
0.131
0.001
-0.003
0.001
-0.004
0.002
-0.012
0.013
0.004
-0.013
0.004
0.004
0.014
0.015
0.041
0.004
-0.005
0.001
0.100
0.002
-0.020
-0.041
-0.017
-0.041
0.001
-0.003
0.005
0.007
-0.062
0.000
-0.014
-0.001
-0.024
0.000
-0.016
-0.058
-0.023
-0.044
0.001
-0.004
0.001
0.004
-0.038
-0.005
-0.025
-0.001
-0.102
-0.001
-0.035
-0.027
-0.015
-0.049
-0.006
-0.015
-0.005
0.009
-0.142
-0.001
-0.026
-0.001
0.003
-0.002
0.011
0.008
0.011
-0.006
0.016
0.024
0.033
0.016
0.183
0.007
0.016
0.002
0.115
0.005
0.024
0.005
0.017
0.019
0.022
0.034
0.041
0.016
0.299
0.007
0.020
0.003
0.094
0.006
0.011
0.053
0.023
0.023
0.014
0.022
0.032
0.021
0.224
0.009
0.016
0.004
0.197
0.005
0.008
0.013
0.007
0.009
0.004
0.007
0.007
0.002
0.063
0.002
0.008
0.001
0.035
0.045
0.010
0.016
0.010
0.016
0.005
0.010
0.010
0.003
0.086
0.003
0.011
0.001
0.050
0.047
0.012
0.020
0.010
0.018
0.005
0.009
0.009
0.003
0.093
0.003
0.011
0.001
0.049
0.002
0.580
0.190
0.660
0.008
0.020
0.130
0.006
<0.0001
0.330
0.080
0.910
0.320
0.200
0.090
0.700
0.100
0.770
0.430
0.040
0.120
0.040
0.001
0.120
0.730
0.820
0.460
0.990
0.200
0.290
0.530
0.680
0.490
0.470
0.700
0.140
<0.0001
0.660
0.110
0.630
0.350
0.040
0.780
CCT: central corneal thickness, HbA1c: glycosylated hemoglobin, FBS: fasting blood sugar, CI: confidence interval, SE: standard error,
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a higher IOP among women with diabetes [2,11].
However, Kawase et al. [32] did not find any gender
difference in IOP. We assume that the increased IOP
among women with elevated glycosylated hemoglobin
in our study is related to accumulation of fibronectin in
trabecular meshwork [12]. Higher prevalence of obesity,
hypertension and probably a higher life expectancy can
best explain higher IOP among women [11]. Similar to
our study, many other studies have reported a higher
prevalence of elevated IOP among subjects with
hypertension [2-4,11]. Although, the rationale for this is
poorly understood, possible reasons could be increased
aqueous humor production by ultrafiltration due to the
elevated ciliary artery pressure, a generalized increase in
the sympathetic tone or elevated serum corticosteroid
levels as seen in hypertension subjects [4].
We found a higher IOP among women with CSME.
The reason for this is unknown. But, this can probably
be explained by a complex interplay between the change
in retinal hemodynamics, ocular perfusion, scleral
rigidity and hormonal influence among women [33].
We found an inverse relationship between the
presence of diabetic neuropathy and IOP. al-Sereiti et al.
[13] reported normal IOP among patients with diabetes
having autonomic neuropathy. However, one study has
shown that autonomic denervation may be a prerequisite
of peripheral diabetic neuropathy [34]. It has been
postulated that in autonomic neuropathy, the pupil/iris
diameter is reduced, which increases the aqueous
drainage, reducing the IOP [13].
Similar to previous studies, alcohol has been shown to
lower the IOP, possibly through a reduction of net water
movement into the eye [35], whereas, smoking was
found to increase the IOP, hypothesized to be due to
smoking induced degenerative changes in the arteries
and increase in blood viscosity [36].
Wu et al. [3] found a positive association between
pulse rate and IOP, similar to our study. Even on
multivariate analysis after adjusting for variables like
age, gender, duration of diabetes, BMI and glycemic
control, the association between the resting pulse rate
and the IOP remained the same.
Like earlier study [37], the present study also found a
negative relationship between height and IOP. However,
one study by Bulpitt et al. [4] found no relationship
between the two. The height of an individual is related to
genetic and acquired factors like status of growth
hormone and childhood nutrition [38] which may
probably affect the IOP. BMI and IOP being directly
proportional, and height being inversely proportional to
BMI [19], we can expect a similar inverse relationship
between height and IOP.
Earlier study has reported a similar relationship
between CCT and IOP among subjects with diabetes
[11]. However, as diabetes affects corneal biomechanics,
this results in lower corneal hysteresis values than those
in healthy control subjects [39]. This may cause
clinically relevant high IOP measurements independent
of CCT. Also, the GAT gives an accurate intraocular
pressure reading for an eye with average CCT, but tends
to underestimate or overestimate the true intraocular
pressure for thinner and thicker cornea, respectively [11].
Our study confirmed this correlation between increasing
IOP and increasing CCT as measured by GAT. 
The strength of this study was that it used photography
and standard grading techniques. Further, the study was
representative of a large population, and the results could
be extrapolated to the whole of urban India. One of the
Table 4. Multivariate associations with intraocular pressure (IOP) in participants of SN-DREAMS 1
Risk factors
Adjusted
Coefficient (ǰ ǰ )
95% CI
Lower bound Upper bound
Standard error Partial r
2 p
Over All
Height (cm)
Pulse (Beats/min)
CCT (Ǻ )
Model r
2
Men
CCT (Ǻ )
Model r
2
Women
CCT (Ǻ )
Model r
2
-0.048
0.001
0.007
0.004
0.008
-0.028
0.015
0.011
0.010
0.015
-0.007
0.029
0.016
0.016
0.021
0.010
0.007
0.002
0.003
0.003
0.005
0.003
0.018
0.037
0.014
0.035
0.031
0.052
0.0070
0.0300
<0.0010
<0.0010
0.0020
<0.0200
<0.0010
0.0020
CCT: central corneal thickness, CI: confidence interval, SN-DREAMS 1: Sankara Nethralaya-diabetic Retinopathy Epidemiology and Molecular Genetic Study. 
The variables adjusted in multiple regression analysis are age, duration of diabetes, weight, height, systolic and diastolic blood pressure, pulse, central corneal
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limitations of this study was the absence of non-diabetic
subjects, including them may have elicited a better
relationship between IOP and subjects with DM. Also,
in subjects with known DM, a second estimation of
blood glucose was not performed; the diagnostic
accuracy of the treating diabetologists was relied upon
totally. The sample size for this study was calculated for
the estimation of the prevalence of diabetic retinopathy
in the general population; the power to elucidate
associated risk factors in the subgroup analysis may be
inadequate. This study does not have any data on
progression, as no follow-up is envisaged. These data
stress on the need for regular ocular examinations in
subjects with type 2 DM in countries like India,
especially for smokers and when associated with
systemic hypertension. Even the IOP distribution in
subjects with type 2 diabetes is gender specific. In
conclusion, identifying the risk factors for high IOP in
this population will prevent blindness in this vulnerable
population. 
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Appendix. Comparison of mean IOP in published population-based reports among type 2 diabetes
Study name Country 
Public-
ation
year
Ethni-
city
Gen-
der
Age
range
(y)
Age 
(mean SD)
(y)
Sam
ple
(n)
IOP
measurement
technique
IOP 
(mean SD)
(mmHg)
Bankes JL [14]
Bouzas AG, et al [15]
Williams B, et al [16]
Wisconsin epidemiologic study [17]
Arora VK, et al [7]
al-Sereiti MR, et al [13]
Beaver dam eye study [3]
Baltimore eye survey [9]
Rotterdam study [18]
Barbados eye study [2]
Barbados incidence study of eye diseases [8]
Oshitari T [12]
Los Angeles Latino eye study [11]
Beijing eye study [10]
Present study 
GAT: goldmann applanation tonometry, IOP: intraocular pressure, SD: standard deviation.
England
New England
England
USA
India
England
USA
USA
Netherland
West Indies
West Indies
Japan
USA
China
India
1967
1971
1980
1984
1989
1991
1992
1995
1996
1997
2003
2007
2008
2009
2010
Mixed
Mixed
Mixed
Mixed
Asian
Mixed
Mixed
Mixed
White
Mixed
Mixed
Japanese
Mexicans
Chinese
Asian
Both
Both
Both
Both
Males
Both
Both
Both
Both
Both
Both
Both
Both
Both
Both
40
51  -  68
25  -  70
0 to >75
NA
NA
43 - 84
40
55
40 - 84
40 - 84
NA
40
45 - 89
40
NA
NA
53.3613.3
NA
NA
.004015
NA
NA
55 - 94
58
057.5 11.5
60.86 10.76
NA
060.4 10
56.32 10.02
212
56
14
2990
46
38
438
714
256
17
559
190
1416
381
1414
GAT
GAT
Perkins handheld
GAT
Schiotz
Non-contact
Pneumotonometer
GAT
GAT
GAT
GAT
GAT
GAT
GAT
Non-contact
Pneumotonometer
GAT
16.69 3.32
15.19 3.15
18.9 2.25
16.3 4.12
19.26
15.53.9
16.05 3.8
17.9 0.24
14.86 2.91
18.6 3.7
21.5 4.7
16.0 2.5
15.2 3.3
16.14 2.96
14.8 2.9